1977
DOI: 10.1530/acta.0.0850422
|View full text |Cite
|
Sign up to set email alerts
|

Oestrogenic Activity of Oestradiol-Decanoate After Oral Administration to Rodents

Abstract: Oestradiol-decanoate, dissolved in arachis oil and orally administered to rodents, produces oestrogenic effects. Compared on a molecular basis the ester has 0.1\p=n-\1.0 times the activity of ethinyl oestradiol, dependent on the species and the parameter studied.The effects of oestradiol-decanoate are less or absent when the oil is omitted. It is likely that absorption of the steroid ester takes place via the intestinal lymphatics in conjunction with the oil. The principal oestrogen, naturally produced by the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1977
1977
2010
2010

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…In one recent study, however, it has been demonstrated that after an intravenous injection of tritiated oestradiol into postmenopausal patients with cancer, the most prevalent oestrogen in the unconjugated oestrogen fraction in the plasma was oestrone (Vaughn et al, 1976). As oestradiol decanoate* had been found in rats to be a potent orally active ester when administered in oily solution (de Visser & van der Vies, 1976), it was of interest to investigate the bioavailability of oestradiol after oral administration of oestradiol decanoate in women. The present study was undertaken to assess effects of oral oestradiol decanoate dissolved in oil, given in a daily dose of 0.5 mg, on plasma levels of oestradiol, oestrone, FSH and LH, as well as on vaginal cytology, cervical mucus and endometrial proliferation.…”
mentioning
confidence: 99%
“…In one recent study, however, it has been demonstrated that after an intravenous injection of tritiated oestradiol into postmenopausal patients with cancer, the most prevalent oestrogen in the unconjugated oestrogen fraction in the plasma was oestrone (Vaughn et al, 1976). As oestradiol decanoate* had been found in rats to be a potent orally active ester when administered in oily solution (de Visser & van der Vies, 1976), it was of interest to investigate the bioavailability of oestradiol after oral administration of oestradiol decanoate in women. The present study was undertaken to assess effects of oral oestradiol decanoate dissolved in oil, given in a daily dose of 0.5 mg, on plasma levels of oestradiol, oestrone, FSH and LH, as well as on vaginal cytology, cervical mucus and endometrial proliferation.…”
mentioning
confidence: 99%